Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Mathew Cherian, Alexa Magner et al.|Frontiers in Oncology|2020Cited by 127
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Robert Wesolowski, Mohamed Badawi et al.|Investigational New Drugs|2020Cited by 37
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Bhuvaneswari Ramaswamy, Jasmine Sukumar et al.|Cardio-Oncology|2020Cited by 32
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast CancerJharna Datta, Mathew Cherian, Natalie Willingham et al.|Frontiers in Oncology|2022Cited by 21
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the LiteratureH. Boutrid, Mathew Cherian, Mahmoud Kassem et al.|Frontiers in Endocrinology|2020Cited by 20